An experimental new type of male contraceptive that blocks sperm flow with a gel has been successful in monkey trials.
Vasalgel acts as a physical barrier once injected into the tubes that sperm would swim down to the penis.
The company behind it says a two-year trial, published in Basic and Clinical Andrology , shows the gel works and is safe - at least in primates.
It hopes to have enough evidence to begin tests in men within a few years.
If those get funding and go well - two big "ifs" - it will seek regulatory approval to make the gel more widely available to men.
It would be the first new type of male contraceptive to hit the market in many decades.
Vasagel is thought to have the same effect as a vasectomy — but another injection should dissolve the gel plug.
http://www.bbc.com/news/health-38879224
Related: The Perfect Birth Control for Men Is Here. Why Can't We Use It?
(Score: 2) by iamjacksusername on Wednesday February 08 2017, @08:41PM
That's absolutely correct; no pharma wants to fund a new drug that is a one-time use per person per lifetime. There is not enough money in it. That's why Parsemus is set up as a social venture corporation. There is not a lot of long-term private profit in this; it is a "social good."